ArticleJournal of molecular histology2025
Resveratrol pretreatment improved the function of mesenchymal stem cells in the recovery of spinal cord injury by stimulating the secretion of nerve growth factor.
Article in Journal of molecular histology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Effects of secretome derived from resveratrol treated mesenchymal stem cell on cornea wound: an organ culture study.Scientific reports · 2026Article
- Current status and future prospects of functionalized mesenchymal stem cells for the treatment of spinal cord injury.Journal of orthopaedic translation · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Depending on its severity, spinal cord injury (SCI) can cause bowel and bladder incontinence, sensory abnormalities, muscle paralysis, and lifelong disability. Enhancing the biological properties of stem cells before transplantation can improve the efficacy of cell therapy. Resveratrol has recently been used to enhance mesenchymal stem cells' (MSCs') paracrine capacity for tissue repair. Our goal was to implant mesenchymal stem cells (MSCs) into a rat spinal cord injury (SCI) model after pre-treating them with resveratrol. First, MSCs were isolated from adipose tissue. Then, the cells were treated with resveratrol, and the amount of nerve growth factor (NGF) in the supernatant was measured. Rats were randomly assigned to four groups and given a weight-drop technique to cause spinal cord injury. MSCs were injected into the site of injury 30 min after SCI. A functional recovery test was conducted over four weeks. Luxal fast blue and hematoxylin-eosin staining were done to evaluate the tissues. The concentration of 0.2 micromolar of resveratrol increased the expression of NGF in the supernatant of MSCs. There was a significant increase in the average motor function scores in the fourth week after the injury in animals that received stem cells treated with resveratrol compared to the SCI group. This study demonstrated that transplanted MSCs treated with resveratrol exhibit better efficacy in promoting functional recovery.
Indexed as
Identifiers
40753358What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.